Early Albumin Infusion Is Associated With Greater Survival to Discharge Among Patients With Sepsis/Septic Shock Who Develop Severe Acute Kidney Injury Among Patients With Sepsis/Septic Shock Who Develop Severe Acute Kidney Injury

Overview

Journal Crit Care Explor

Specialty Critical Care

Date 2022 Dec 30

PMID 36583206

Authors

Karthik Raghunathan

Jordan A Kempker

E Anne Davis

Navreet S Sindhwani

Santosh Telang

Kunal Lodaya

Greg S Martin

Affiliations

Soon will be listed here.

Abstract

Objectives: To examine the association between early use of albumin and time to discharge in adults who develop severe AKI while hospitalized with sepsis/septic shock.

Design: Retrospective cohort study using de-identified electronic health records from a national database (Cerner Health Facts; Cerner Corp., Kansas City, MO).

Setting And Participants: Patients ( = 2,829) hospitalized between January 2013 and April 2018 with a diagnosis of sepsis/septic shock (identified using , 9th Revision and 10th Revision codes) who developed severe AKI (stage 3 according to Kidney Disease Improving Global Outcomes criteria) during hospitalization ( = 2,845 unique encounters).

Main Outcomes And Measures: Patients were grouped according to timing of albumin exposure: within less than or equal to 24 hours of admission ("early albumin") or unexposed/exposed late ("nonearly albumin"). A cause-specific hazard model, censoring for death/discharge to hospice, was used to examine the association between "early albumin" and the rate of hospital discharge with clinical stability.

Results: Albumin was administered early in 8.6% of cases. Cases with early albumin administration had a median time to discharge of 13.2 days compared with 17.0 in the nonearly group (Log-rank < 0.0001). An adjusted analysis showed that the rate of hospital discharge with clinical stability increased by 83% in the early albumin group compared with the nonearly group (hazard ratio, 1.832; 95% CI, 1.564-2.146; < 0.001 nonearly group.

Conclusions And Relevance: The use of albumin within 24 hours of hospital admission was associated with a shorter time to discharge and a higher rate of discharge with clinical stability, suggesting an improvement in healthcare resource utilization among patients with sepsis/septic shock who developed stage 3 AKI during hospitalization.

Citing Articles

Association of high fibrinogen to albumin ratio with long-term mortality in patients with spontaneous intracerebral hemorrhage.

Chen S, Zhang Y, Xiao Y, Cheng X, Peng L, Tian Y Front Neurol. 2024; 15:1412804.

PMID: 39099785 PMC: 11294216. DOI: 10.3389/fneur.2024.1412804.

The association between albumin and mortality in patients with acute kidney injury: a retrospective observational study.

Yang K, Yang N, Sun W, Dai L, Jin J, Wu J BMC Nephrol. 2023; 24(1):332.

PMID: 37946135 PMC: 10636863. DOI: 10.1186/s12882-023-03323-x.

Heme Scavenging and Delivery: The Role of Human Serum Albumin.

De Simone G, Varricchio R, Ruberto T, Di Masi A, Ascenzi P Biomolecules. 2023; 13(3).

PMID: 36979511 PMC: 10046553. DOI: 10.3390/biom13030575.

Erratum: Early Albumin Infusion Is Associated With Greater Survival to Discharge Among Patients With Sepsis/Septic Shock Who Develop Severe Acute Kidney Injury Among Patients With Sepsis/Septic Shock Who Develop Severe Acute Kidney Injury: Erratum.

Crit Care Explor. 2023; 5(1):e0852.

PMID: 36699253 PMC: 9851673. DOI: 10.1097/CCE.0000000000000852.

References

Martin G, Mangialardi R, Wheeler A, Dupont W, Morris J, Bernard G . Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med. 2002; 30(10):2175-82. DOI: 10.1097/00003246-200210000-00001. View

Rhee C, Jones T, Hamad Y, Pande A, Varon J, OBrien C . Prevalence, Underlying Causes, and Preventability of Sepsis-Associated Mortality in US Acute Care Hospitals. JAMA Netw Open. 2019; 2(2):e187571. PMC: 6484603. DOI: 10.1001/jamanetworkopen.2018.7571. View

Bagshaw S, George C, Bellomo R . Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care. 2008; 12(2):R47. PMC: 2447598. DOI: 10.1186/cc6863. View

Xu J, Chen Q, Xie J, Pan C, Liu S, Huang L . Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials. Crit Care. 2014; 18(6):702. PMC: 4284920. DOI: 10.1186/s13054-014-0702-y. View

White L, Hassoun H, Bihorac A, Moore L, Sailors R, McKinley B . Acute kidney injury is surprisingly common and a powerful predictor of mortality in surgical sepsis. J Trauma Acute Care Surg. 2013; 75(3):432-8. PMC: 3823059. DOI: 10.1097/TA.0b013e31829de6cd. View

Salerno F, Gerbes A, Gines P, Wong F, Arroyo V . Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007; 56(9):1310-8. PMC: 1954971. DOI: 10.1136/gut.2006.107789. View

Perel P, Roberts I, Ker K . Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2013; (2):CD000567. DOI: 10.1002/14651858.CD000567.pub6. View

Ethgen O, Schneider A, Bagshaw S, Bellomo R, Kellum J . Economics of dialysis dependence following renal replacement therapy for critically ill acute kidney injury patients. Nephrol Dial Transplant. 2014; 30(1):54-61. PMC: 4286762. DOI: 10.1093/ndt/gfu314. View

Jeganathan N, Ahuja N, Yau S, Otu D, Stein B, Balk R . Impact of End-Stage Renal Disease and Acute Kidney Injury on ICU Outcomes in Patients With Sepsis. J Intensive Care Med. 2016; 32(7):444-450. DOI: 10.1177/0885066616645308. View

10.

Martin G, Moss M, Wheeler A, Mealer M, Morris J, Bernard G . A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med. 2005; 33(8):1681-7. DOI: 10.1097/01.ccm.0000171539.47006.02. View

11.

Ge C, Peng Q, Chen W, Li W, Zhang L, Ai Y . Association between albumin infusion and outcomes in patients with acute kidney injury and septic shock. Sci Rep. 2021; 11(1):24083. PMC: 8677767. DOI: 10.1038/s41598-021-03122-0. View

12.

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

13.

Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Castells L . Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999; 341(6):403-9. DOI: 10.1056/NEJM199908053410603. View

14.

Gomez H, Ince C, De Backer D, Pickkers P, Payen D, Hotchkiss J . A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock. 2013; 41(1):3-11. PMC: 3918942. DOI: 10.1097/SHK.0000000000000052. View

15.

Hammond N, Taylor C, Finfer S, Machado F, An Y, Billot L . Patterns of intravenous fluid resuscitation use in adult intensive care patients between 2007 and 2014: An international cross-sectional study. PLoS One. 2017; 12(5):e0176292. PMC: 5428917. DOI: 10.1371/journal.pone.0176292. View

16.

Martin G, Bassett P . Crystalloids vs. colloids for fluid resuscitation in the Intensive Care Unit: A systematic review and meta-analysis. J Crit Care. 2018; 50:144-154. DOI: 10.1016/j.jcrc.2018.11.031. View

17.

Dirkes S . Sepsis and inflammation: impact on acute kidney injury. Nephrol Nurs J. 2013; 40(2):125-32. View

18.

Zarbock A, Gomez H, Kellum J . Sepsis-induced acute kidney injury revisited: pathophysiology, prevention and future therapies. Curr Opin Crit Care. 2014; 20(6):588-95. PMC: 4495653. DOI: 10.1097/MCC.0000000000000153. View

19.

Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M . Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014; 370(15):1412-21. DOI: 10.1056/NEJMoa1305727. View

20.

Vincent J, De Backer D, Wiedermann C . Fluid management in sepsis: The potential beneficial effects of albumin. J Crit Care. 2016; 35:161-7. DOI: 10.1016/j.jcrc.2016.04.019. View